missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human IL-7 Recombinant Protein, PeproTech®
Recombinant Protein
Marque: Gibco™ 200-07-10UG
172.55 EUR valable jusqu'au 2025-06-30
Utilisez le code promo "24074" pour bénéficier de cette offre.
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
200-07-1MG will be provided as 2 x 500 μg (200-07-500UG). Recombinant Human IL-7 is a 17.5 kDa protein containing 153 amino acid residues. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
Interleukin 7 (IL-7) is a hematopoietic cytokine that is constitutively produced by stromal cells from the bone marrow and thymus. IL-7 signals through the IL-7R to promote the differentiation of hematopoietic stem cells to lymphoid precursor cells, which give rise to T cells, B cells, and natural killer cells.
Spécification
| P13232, P16871 | |
| protein with no preservative | |
| 17.5 kDa | |
| 10 μg | |
| RUO | |
| A630026I06Rik; H-IL-7; hlb368; IL7; Il-7; ILN; Interleukin; interleukin 7; Interleukin7; interleukin-7; M-IL-7 | |
| Il7 | |
| Unconjugated | |
| MDCDIEGKDG KQYESVLMVS IDQLLDSMKE IGSNCLNNEF NFFKRHICDA NKEGMFLFRA ARKLRQFLKM NSTGDFDLHL LKVSEGTTIL LNCTGQVKGR KPAALGEAQP TKSLEENKSL KEQKKLNDLC FLKRLLQEIK TCWNKILMGT KEH | |
| E. coli | |
| ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| ELISA, Functional Assay, Western Blot | |
| 3574, 3575 | |
| Human IL-7 | |
| E. coli | |
| <1 EU/ μg | |
| IL-7 | |
| The ED50 was determined by the dose-dependent stimulation of the proliferation of murine 2E8 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 10^6 units/mg | |
| Recombinant | |
| -20°C | |
| Lyophilized |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Gibco™ Human IL-7 Recombinant Protein, PeproTech® > 10 μg; Unlabeled
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu
